Your company is developing antiviral drugs called nucleoside analog inhibitors. In particular the drug is a uridine analog used to inhibit HCV. Use of this drug leads to termination of viral replication because it binds to the active site of: Select one: a. RNA dependent DNA polymerase b. RNA dependent RNA polymerase c. DNA dependent DNA polymerase d. DNA dependent RNA polymerase
Added by Kayla P.
Step 1
Since it inhibits HCV (Hepatitis C Virus), which is an RNA virus, the drug must be targeting an enzyme involved in RNA replication. The options are: a. RNA dependent DNA polymerase: This enzyme synthesizes DNA using an RNA template, which is not the case for HCV Show more…
Show all steps
Your feedback will help us improve your experience
Labs
Want to see this concept in action?
Explore this concept interactively to see how it behaves as you change inputs.
Key Concepts
Recommended Videos
You start the patient on a combination of treatments including TDF (Tenofovir) which is a reverse transcriptase inhibitor medication and RTV (Ritonavir) which is a protease inhibitor. RTI medications prevent the viral RNA polymerase from creating DNA sequences and protease inhibitors prevent formation of functional proteins. The use of these two medications are blocking which stage of viral replication? A. Uncoating B. Penetration C. Synthesis D. Release E. Adsorption
Marlyn J.
Most viruses have either an icosahedral or helical structural protein that surrounds the nucleic acid genome. What is this structural component called? Select one: a. Viral attachment protein (VAP) b. DNA-dependent DNA polymerase c. RNA-dependent polymerase d. Nucleocapsid e. Envelope
Sri K.
Recommended Textbooks
Biology for AP Courses
Objective Biology for NEET
Introduction to General, Organic and Biochemistry
Transcript
Watch the video solution with this free unlock.
EMAIL
PASSWORD